← All stocks

GILD vs SNY

Gilead Sciences Inc. Common Stock vs Sanofi ADS. Side-by-side ACCE scores, valuation, profitability, and growth.

GILD
Gilead Sciences Inc. Common Stock
Healthcare
150.56
186.13B
SNY
Sanofi ADS
Healthcare
42.50
101.79B
ACCE scores
GILD
SNY
Composite score
Out of 100
64
59
Growth
76
40
Value
40
80
Quality
55
75
Momentum
83
40
Valuation
GILD
SNY
Price
150.56
42.50
Market cap
186.13B
101.79B
Trailing P/E
0.00
22.96
Forward P/E
15.29
8.58
EV / EBITDA
116.03
12.84
Dividend yield
2.1%
9.6%
Profitability
GILD
SNY
ROE
-20.7%
5.7%
Net margin
-10.6%
8.1%
Debt / equity
1.10
0.26
Free cash flow
9.46B
10.14B
Growth
GILD
SNY
Revenue growth (YoY)
10.2%
14.6%
Earnings growth (YoY)
54.8%
-91.2%
Analyst target
158.15
53.72
See full analysis